The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.

Someone is considered to be diabetic if the blood glucose/sugar levels are persistently above normal. People with diabetes usually have problems converting food nutrients into energy for their body ...

Lilly isn’t the first diabetes specialist to tap into Dexcom ... Roche’s diagnostics division – to develop connected insulin pens. “CGMs provide people with diabetes and their healthcare ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The average wholesale prices of the originator insulin are around $329 per vial and $510 for five pens, according to Civica ... was welcomed by the American Diabetes Association and The Endocrine ...

SLOWLY lifting her head off her sweat-drenched pillow, Aisleyne Horgan-Wallace vomits into the sick bucket next to her bed. ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

Part of what makes medical emergencies so scary is that, by nature, they can happen completely unexpectedly.

Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.